These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 12747794)

  • 21. 3-phenyl-6-(2-pyridyl)methyloxy-1,2,4-triazolo[3,4-a]phthalazines and analogues: high-affinity gamma-aminobutyric acid-A benzodiazepine receptor ligands with alpha 2, alpha 3, and alpha 5-subtype binding selectivity over alpha 1.
    Carling RW; Moore KW; Street LJ; Wild D; Isted C; Leeson PD; Thomas S; O'Connor D; McKernan RM; Quirk K; Cook SM; Atack JR; Wafford KA; Thompson SA; Dawson GR; Ferris P; Castro JL
    J Med Chem; 2004 Mar; 47(7):1807-22. PubMed ID: 15027873
    [TBL] [Abstract][Full Text] [Related]  

  • 22. GABA A receptor subtype selectivity underlying selective anxiolytic effect of baicalin.
    Wang F; Xu Z; Ren L; Tsang SY; Xue H
    Neuropharmacology; 2008 Dec; 55(7):1231-7. PubMed ID: 18723037
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SL651498: an anxioselective compound with functional selectivity for alpha2- and alpha3-containing gamma-aminobutyric acid(A) (GABA(A)) receptors.
    Griebel G; Perrault G; Simiand J; Cohen C; Granger P; Decobert M; Françon D; Avenet P; Depoortere H; Tan S; Oblin A; Schoemaker H; Evanno Y; Sevrin M; George P; Scatton B
    J Pharmacol Exp Ther; 2001 Aug; 298(2):753-68. PubMed ID: 11454940
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Selective GABA(A) α5 positive allosteric modulators improve cognitive function in aged rats with memory impairment.
    Koh MT; Rosenzweig-Lipson S; Gallagher M
    Neuropharmacology; 2013 Jan; 64(1):145-52. PubMed ID: 22732440
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Discovery of functionally selective 7,8,9,10-tetrahydro-7,10-ethano-1,2,4-triazolo[3,4-a]phthalazines as GABA A receptor agonists at the alpha3 subunit.
    Russell MG; Carling RW; Atack JR; Bromidge FA; Cook SM; Hunt P; Isted C; Lucas M; McKernan RM; Mitchinson A; Moore KW; Narquizian R; Macaulay AJ; Thomas D; Thompson SA; Wafford KA; Castro JL
    J Med Chem; 2005 Mar; 48(5):1367-83. PubMed ID: 15743180
    [TBL] [Abstract][Full Text] [Related]  

  • 26. (R)-3'-(3-methylbenzo[b]thiophen-5-yl)spiro[1-azabicyclo[2,2,2]octane-3,5'-oxazolidin]-2'-one, a novel and potent alpha7 nicotinic acetylcholine receptor partial agonist displays cognitive enhancing properties.
    Tatsumi R; Fujio M; Takanashi S; Numata A; Katayama J; Satoh H; Shiigi Y; Maeda J; Kuriyama M; Horikawa T; Murozono T; Hashimoto K; Tanaka H
    J Med Chem; 2006 Jul; 49(14):4374-83. PubMed ID: 16821797
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vivo labelling of alpha5 subunit-containing GABA(A) receptors using the selective radioligand [(3)H]L-655,708.
    Atack JR; Alder L; Cook SM; Smith AJ; McKernan RM
    Neuropharmacology; 2005 Aug; 49(2):220-9. PubMed ID: 15996568
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis, in vitro affinity, and efficacy of a bis 8-ethynyl-4H-imidazo[1,5a]- [1,4]benzodiazepine analogue, the first bivalent alpha5 subtype selective BzR/GABA(A) antagonist.
    Li X; Cao H; Zhang C; Furtmueller R; Fuchs K; Huck S; Sieghart W; Deschamps J; Cook JM
    J Med Chem; 2003 Dec; 46(26):5567-70. PubMed ID: 14667209
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Potent 4-arylalkyl-substituted 3-isothiazolol GABA(A) competitive/noncompetitive antagonists: synthesis and pharmacology.
    Krehan D; Storustovu SI; Liljefors T; Ebert B; Nielsen B; Krogsgaard-Larsen P; Frølund B
    J Med Chem; 2006 Feb; 49(4):1388-96. PubMed ID: 16480274
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 6,3'-Dinitroflavone is a low efficacy modulator of GABA(A) receptors.
    Furtmueller R; Furtmueller B; Ramerstorfer J; Paladini AC; Wasowski C; Marder M; Huck S; Sieghart W
    Eur J Pharmacol; 2008 Sep; 591(1-3):142-6. PubMed ID: 18639544
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 3-Heteroaryl-2-pyridones: benzodiazepine site ligands with functional delectivity for alpha 2/alpha 3-subtypes of human GABA(A) receptor-ion channels.
    Collins I; Moyes C; Davey WB; Rowley M; Bromidge FA; Quirk K; Atack JR; McKernan RM; Thompson SA; Wafford K; Dawson GR; Pike A; Sohal B; Tsou NN; Ball RG; Castro JL
    J Med Chem; 2002 Apr; 45(9):1887-900. PubMed ID: 11960500
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis and evaluation of analogues of the partial agonist 6-(propyloxy)-4-(methoxymethyl)-beta-carboline-3-carboxylic acid ethyl ester (6-PBC) and the full agonist 6-(benzyloxy)-4-(methoxymethyl)-beta-carboline-3-carboxylic acid ethyl ester (Zk 93423) at wild type and recombinant GABAA receptors.
    Cox ED; Diaz-Arauzo H; Huang Q; Reddy MS; Ma C; Harris B; McKernan R; Skolnick P; Cook JM
    J Med Chem; 1998 Jul; 41(14):2537-52. PubMed ID: 9651158
    [TBL] [Abstract][Full Text] [Related]  

  • 33. GABAA receptor pharmacology of fluorinated derivatives of the novel sedative-hypnotic pyrazolopyrimidine indiplon.
    Wegner F; Deuther-Conrad W; Scheunemann M; Brust P; Fischer S; Hiller A; Diekers M; Strecker K; Wohlfarth K; Allgaier C; Steinbach J; Hoepping A
    Eur J Pharmacol; 2008 Feb; 580(1-2):1-11. PubMed ID: 18035350
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 7-(1,1-Dimethylethyl)-6-(2-ethyl-2H-1,2,4-triazol-3-ylmethoxy)-3-(2-fluorophenyl)-1,2,4-triazolo[4,3-b]pyridazine: a functionally selective gamma-aminobutyric acid(A) (GABA(A)) alpha2/alpha3-subtype selective agonist that exhibits potent anxiolytic activity but is not sedating in animal models.
    Carling RW; Madin A; Guiblin A; Russell MG; Moore KW; Mitchinson A; Sohal B; Pike A; Cook SM; Ragan IC; McKernan RM; Quirk K; Ferris P; Marshall G; Thompson SA; Wafford KA; Dawson GR; Atack JR; Harrison T; Castro JL; Street LJ
    J Med Chem; 2005 Nov; 48(23):7089-92. PubMed ID: 16279764
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PWZ-029, a compound with moderate inverse agonist functional selectivity at GABA(A) receptors containing alpha5 subunits, improves passive, but not active, avoidance learning in rats.
    Savić MM; Clayton T; Furtmüller R; Gavrilović I; Samardzić J; Savić S; Huck S; Sieghart W; Cook JM
    Brain Res; 2008 May; 1208():150-9. PubMed ID: 18394590
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Imidazo[1,2-a]pyrazin-8-ones, imidazo[1,2-d][1,2,4]triazin-8-ones and imidazo[2,1-f][1,2,4]triazin-8-ones as alpha2/alpha3 subtype selective GABA A agonists for the treatment of anxiety.
    Goodacre SC; Hallett DJ; Carling RW; Castro JL; Reynolds DS; Pike A; Wafford KA; Newman R; Atack JR; Street LJ
    Bioorg Med Chem Lett; 2006 Mar; 16(6):1582-5. PubMed ID: 16384707
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predictive models for GABAA/benzodiazepine receptor subtypes: studies of quantitative structure-activity relationships for imidazobenzodiazepines at five recombinant GABAA/benzodiazepine receptor subtypes [alphaxbeta3gamma2 (x = 1-3, 5, and 6)] via comparative molecular field analysis.
    Huang Q; Liu R; Zhang P; He X; McKernan R; Gan T; Bennett DW; Cook JM
    J Med Chem; 1998 Oct; 41(21):4130-42. PubMed ID: 9767648
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A pyridazine series of alpha2/alpha3 subtype selective GABA A agonists for the treatment of anxiety.
    Lewis RT; Blackaby WP; Blackburn T; Jennings AS; Pike A; Wilson RA; Hallett DJ; Cook SM; Ferris P; Marshall GR; Reynolds DS; Sheppard WF; Smith AJ; Sohal B; Stanley J; Tye SJ; Wafford KA; Atack JR
    J Med Chem; 2006 Apr; 49(8):2600-10. PubMed ID: 16610803
    [TBL] [Abstract][Full Text] [Related]  

  • 39. GABA-based therapeutic approaches: GABAA receptor subtype functions.
    Rudolph U; Möhler H
    Curr Opin Pharmacol; 2006 Feb; 6(1):18-23. PubMed ID: 16376150
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Imidazo[1,2-b][1,2,4]triazines as alpha2/alpha3 subtype selective GABA A agonists for the treatment of anxiety.
    Jennings AS; Lewis RT; Russell MG; Hallett DJ; Street LJ; Castro JL; Atack JR; Cook SM; Lincoln R; Stanley J; Smith AJ; Reynolds DS; Sohal B; Pike A; Marshall GR; Wafford KA; Sheppard WF; Tye SJ
    Bioorg Med Chem Lett; 2006 Mar; 16(6):1477-80. PubMed ID: 16386900
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.